Jazz Pharmaceuticals Plc Share Price Today
(NASDAQ: JAZZ)

Name: Jazz Pharmaceuticals Plc Share Price Today (NASDAQ: JAZZ) - Jazz Pharmaceuticals Plc Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Jazz Pharmaceuticals Plc share price is $136.86 & ₹11,935.22 as on 12 Mar 2025, 19.44 hrs IST

$136.86

▲

-0.59

(-0.43%)

Market is closed - opens 7 PM, 12 Mar 2025

View live Jazz Pharmaceuticals Plc share price in Dollar and Rupees. Guide to invest in Jazz Pharmaceuticals Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Jazz Pharmaceuticals Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Jazz Pharmaceuticals Plc share price movements

Today's Low: $134.64
Today's High: $138.49
$136.86
1.62%
Downside
Day's Volatility :2.78%
Upside
1.18%
52 Weeks Low: $99.06
52 Weeks High: $148.06
$136.86
27.62%
Downside
52 Weeks Volatility :33.09%
Upside
7.56%

Jazz Pharmaceuticals Plc (JAZZ) Returns

Period	Jazz Pharmaceuticals Plc	Sector (Health Care)	Index (Russel 2000)
3 Months	13.37%	3.6%	0.0%
6 Months	30.18%	-6.3%	0.0%
1 Year	18.2%	-0.7%	0.0%
3 Years	-11.09%	13.3%	-10.6%

Jazz Pharmaceuticals Plc (JAZZ) Key Statistics

in dollars & INR

Previous Close	$136.86
Open	$136.84
Today's High	$137.015
Today's Low	$135.685
Market Capitalization	$8.3B
Today's Volume	$905.1K
52 Week High	$148.0568
52 Week Low	$99.06
Revenue TTM	$4.1B
EBITDA	$1.5B
Earnings Per Share (EPS)	$8.65
PE Ratio	15.82
Profit Margin	13.77%
Quarterly Earnings Growth YOY	1.19%
Return On Equity TTM	14.31%

How to invest in Jazz Pharmaceuticals Plc Stock (JAZZ) from India?

It is very easy for Indian residents to invest directly in Jazz Pharmaceuticals Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Jazz Pharmaceuticals Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Jazz Pharmaceuticals Plc or JAZZ on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Jazz Pharmaceuticals Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Jazz Pharmaceuticals Plc shares which would translate to 0.006 fractional shares of Jazz Pharmaceuticals Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Jazz Pharmaceuticals Plc, in just a few clicks!

Returns in Jazz Pharmaceuticals Plc (JAZZ) for Indian investors in Rupees

The Jazz Pharmaceuticals Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Jazz Pharmaceuticals Plc investment value today

Current value as on today

₹1,23,599

Returns

₹23,599

(+23.6%)

Returns from Jazz Pharmaceuticals Plc Stock

₹18,197 (+18.2%)

Dollar Returns

₹5,402 (+5.4%)

Indian investors sentiment towards Jazz Pharmaceuticals Plc (JAZZ)

422%

Period: Feb 9, 2025 to Mar 11, 2025. Change in 30 Days versus previous period

Search interest for Jazz Pharmaceuticals Plc Stock from India on INDmoney has increased by 422% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Jazz Pharmaceuticals Plc

Vanguard Group Inc
9.94%
BlackRock Inc
9.63%
LSV Asset Management
4.17%
Pacer Advisors, INC.
3.65%
Dimensional Fund Advisors, Inc.
3.35%
State Street Corp
3.24%

Analyst Recommendation on Jazz Pharmaceuticals Plc

Buy

80%Buy

20%Hold

0%Sell

Based on 25 Wall street analysts offering stock ratings for Jazz Pharmaceuticals Plc(by analysts ranked 0 to 5 stars)

Based on 25 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Jazz Pharmaceuticals Plc Stock (JAZZ)

What analysts predicted

Upside of 40.06%

Target:

$191.68

Current:

$136.86

Insights on Jazz Pharmaceuticals Plc Stock (Ticker Symbol: JAZZ)

Price Movement
In the last 1 month, JAZZ stock has moved up by 1.0%
Increasing Revenue
Revenue is up for the last 4 quarters, 901.98M → 1.08B (in $), with an average increase of 6.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 215.05M → 191.11M (in $), with an average decrease of 11.1% per quarter
JAZZ vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 44.6%
JAZZ vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 54.1% return, outperforming this stock by 65.6%
Price to Sales
ForJAZZ every $1 of sales, investors are willing to pay $2.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.6 for every $1 of sales.

JAZZ Jazz Pharmaceuticals Plc Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$2.2B	↑ 14.32%
Net Income	$523.4M	↑ 17.06%
Net Profit Margin	24.21%	↑ 0.57%

	FY20	Y/Y Change
Revenue	$2.4B	↑ 9.34%
Net Income	$238.6M	↓ 54.41%
Net Profit Margin	10.1%	↓ 14.11%

	FY21	Y/Y Change
Revenue	$3.1B	↑ 30.91%
Net Income	$-329.0M	↓ 237.86%
Net Profit Margin	-10.63%	↓ 20.73%

	FY22	Y/Y Change
Revenue	$3.7B	↑ 18.26%
Net Income	$-214.1M	↓ 34.9%
Net Profit Margin	-5.85%	↑ 4.78%

	FY23	Y/Y Change
Revenue	$3.8B	↑ 4.78%
Net Income	$414.8M	↓ 293.72%
Net Profit Margin	10.82%	↑ 16.67%

	FY24	Y/Y Change
Revenue	$4.1B	↑ 6.12%
Net Income	$560.1M	↑ 35.02%
Net Profit Margin	13.77%	↑ 2.95%

	Q3 FY23	Q/Q Change
Revenue	$972.1M	↑ 1.55%
Net Income	$146.8M	↑ 40.58%
Net Profit Margin	15.1%	↑ 4.19%

	Q4 FY23	Q/Q Change
Revenue	$1.0B	↑ 4.09%
Net Income	$94.2M	↓ 35.87%
Net Profit Margin	9.3%	↓ 5.8%

	Q1 FY24	Q/Q Change
Revenue	$902.0M	↓ 10.87%
Net Income	$-14.6M	↓ 115.53%
Net Profit Margin	-1.62%	↓ 10.92%

	Q2 FY24	Q/Q Change
Revenue	$1.0B	↑ 13.51%
Net Income	$168.6M	↓ 1253.15%
Net Profit Margin	16.46%	↑ 18.08%

	Q3 FY24	Q/Q Change
Revenue	$1.1B	↑ 3.04%
Net Income	$215.1M	↑ 27.58%
Net Profit Margin	20.38%	↑ 3.92%

	Q4 FY24	Q/Q Change
Revenue	$1.1B	↑ 3.15%
Net Income	$191.1M	↓ 11.13%
Net Profit Margin	17.56%	↓ 2.82%

	FY19	Y/Y Change
Profit	$2.0B	↑ 14.95%

	FY20	Y/Y Change
Profit	$2.2B	↑ 8.89%

	FY21	Y/Y Change
Profit	$2.7B	↑ 19.81%

	FY22	Y/Y Change
Profit	$3.1B	↑ 17.54%

	FY23	Y/Y Change
Profit	$3.4B	↑ 8.97%

	FY24	Y/Y Change
Profit	$4.1B	↑ 19.72%

	Q3 FY23	Q/Q Change
Profit	$870.0M	↑ 1.19%

	Q4 FY23	Q/Q Change
Profit	$753.1M	↓ 13.43%

	Q1 FY24	Q/Q Change
Profit	$650.8M	↓ 13.59%

	Q2 FY24	Q/Q Change
Profit	$758.7M	↑ 16.59%

	Q3 FY24	Q/Q Change
Profit	$943.4M	↑ 24.34%

	Q4 FY24	Q/Q Change
Profit	$1.1B	↑ 15.35%

	FY19	Y/Y Change
Operating Cash Flow	$776.4M	↓ 2.82%
Investing Cash Flow	$-155.3M	↓ 60.63%
Financing Cash Flow	$-293.7M	↓ 38.69%

	FY20	Y/Y Change
Operating Cash Flow	$899.6M	↑ 15.87%
Investing Cash Flow	$-1.0B	↑ 548.85%
Financing Cash Flow	$528.1M	↓ 279.77%

	FY21	Y/Y Change
Operating Cash Flow	$778.5M	↓ 13.47%
Investing Cash Flow	$-5.2B	↑ 417.25%
Financing Cash Flow	$4.0B	↑ 651.89%

	FY22	Y/Y Change
Operating Cash Flow	$1.3B	↑ 63.39%
Investing Cash Flow	$-446.2M	↓ 91.44%
Financing Cash Flow	$-529.5M	↓ 113.34%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$307.2M	↑ 3.51%
Investing Cash Flow	$-174.3M	↑ 103.29%
Financing Cash Flow	$-78.5M	↓ 18.8%

Jazz Pharmaceuticals Plc Technicals Summary

Sell

Neutral

Buy

Jazz Pharmaceuticals Plc is currently in a neutral trading position according to technical analysis indicators.

Jazz Pharmaceuticals Plc (JAZZ) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Jazz Pharmaceuticals Plc	10.81%	30.18%	18.2%	-11.09%	22.91%
Regeneron Pharmaceuticals, Inc.	4.03%	-37.08%	-26.01%	9.41%	54.26%
Beone Medicines Ltd	11.85%	16.37%	50.05%	67.46%	69.92%
Vertex Pharmaceuticals Incorporated	3.91%	2.86%	18.4%	102.06%	121.11%
Alnylam Pharmaceuticals, Inc.	-12.89%	-8.85%	62.8%	57.27%	135.05%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Jazz Pharmaceuticals Plc	15.82	15.82	0.43	23.41	0.14	0.05	NA	67.52
Regeneron Pharmaceuticals, Inc.	18.45	18.45	1.04	42.83	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.42	18.06	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Jazz Pharmaceuticals Plc	Buy	$8.3B	22.91%	15.82	13.77%
Regeneron Pharmaceuticals, Inc.	Buy	$80.1B	54.26%	18.45	31.07%
Beone Medicines Ltd	NA	$27.4B	69.92%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.4B	121.11%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.6B	135.05%	NA	-12.37%

About Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Xyrem for the treatment of cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Defitelio to treat severe veno-occlusive disease; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab in Phase 3 trial to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Epidiolex in Phase 3 trial to treat LGS, DS, and TSC; Suvecaltamide in Phase 2 trial to treat Parkinson's disease tremor; JZP815, a pan-RAF kinase inhibitor in Phase 1 trial that targets components of the mitogen-activated protein kinase; JZP898, a conditionally activated interferon alpha molecule in Phase 1 trial; JZP441 in Phase 1 trial to treat narcolepsy, IH, and other sleep disorders; JZP324, an extended-release low sodium oxybate formulation in Phase 1 trial for patients with sleep disorders; and JZP150 to treat post-traumatic stress disorder. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.

Organization	Jazz Pharmaceuticals Plc
Employees	2800
CEO	Mr. Bruce C. Cozadd
Industry	Health Technology

Management People of Jazz Pharmaceuticals Plc

Name	Title
Mr. Bruce C. Cozadd	Co-Founder, Chairman & CEO
Ms. Renee D. Gala	President & COO
Ms. Patricia Carr	Senior VP & Chief Accounting Officer
Ms. Neena M. Patil J.D.	Executive VP & Chief Legal Officer
Dr. Robert Iannone M.D.	Executive VP, Chief Medical Officer and Global Head of Research & Development
Mr. Philip L. Johnson	Executive VP & CFO
Mr. Jeff Macdonald	Executive Director of Investor Relations
Kristin Bhavnani	Head of Global Corporate Communications
Ms. Heidi Manna	Executive VP & Chief People Officer
Dr. Jed Black M.D.	Senior Vice President of Sleep & CNS Medicine

Important FAQs about investing in JAZZ Stock from India :

What is Jazz Pharmaceuticals Plc share price today?

Jazz Pharmaceuticals Plc share price today stands at $136.86, Open: $136.84 ; Previous Close: $137.45 ; High: $138.49 ; Low: $134.64 ; 52 Week High: $148.06 ; 52 Week Low: $99.06.

The stock opens at $136.84, after a previous close of $137.45. The stock reached a daily high of $138.49 and a low of $134.64, with a 52-week high of $148.06 and a 52-week low of $99.06.

Can Indians buy Jazz Pharmaceuticals Plc shares?

Yes, Indians can invest in the Jazz Pharmaceuticals Plc (JAZZ) from India.

With INDmoney, you can buy Jazz Pharmaceuticals Plc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Jazz Pharmaceuticals Plc at zero transaction cost.

How can I buy Jazz Pharmaceuticals Plc shares from India?

It is very easy to buy Jazz Pharmaceuticals Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Jazz Pharmaceuticals Plc (JAZZ) be purchased?

Yes, you can buy fractional shares of Jazz Pharmaceuticals Plc with INDmoney app.

What are the documents required to start investing in Jazz Pharmaceuticals Plc stocks?

To start investing in Jazz Pharmaceuticals Plc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.